Figure 1.
Cumulative incidence of SPM from start of lenalidomide. Two‐year cumulative incidence rate was 3.12% (95% CI, 0–8.5%).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.